WishGarden Herbs Issues Voluntary National Recall of 46 Units of Happy Ducts Compress Due to Bacterial Contamination

Murilo Freitas - 05:00, 30 de noviembre de 2020392

WishGarden Herbs, Inc. is voluntarily recalling one lot of Happy Ducts Compress to the consumer level. After becoming aware of a possible supply chain contamination, a retained product was found to contain the Cronobacter sakazakii bacteria. WishGarden has initiated this recall due to the possible

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/wishgarden-herbs-issues-voluntary-national-recall-46-units-happy-ducts-compress-due-bacterial

rss rss-es rss-pt

Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane

Murilo Freitas - 05:00, 30 de noviembre de 2020385

Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/74479a-eng.php

rss rss-es rss-pt

Baxter Healthcare Recalls Baxter SIGMA Spectrum Infusion Pumps with Master Drug Library (Versions 6 and 8) and Spectrum IQ Infusion Systems with Dose IQ Safety Software Due to Unplanned Shutdown Issues

Murilo Freitas - 05:00, 30 de noviembre de 2020281

Baxter Sigma Spectrum Infusion Pumps w/ Master Drug Library (V. 6 & 8) and Spectrum IQ Infusion Systems with DoseIQ Safety Software deliver fluids into the body

http://www.fda.gov/medical-devices/medical-device-recalls/baxter-healthcare-recalls-baxter-sigma-spectrum-infusion-pumps-master-drug-library-versions-6-and-8

rss rss-es rss-pt

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

Murilo Freitas - 22:01, 29 de noviembre de 2020439

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-second-covid-19-vaccine

rss rss-es rss-pt

HeyPur (2020-11-30)

Murilo Freitas - 05:00, 29 de noviembre de 2020370

HeyPur (2020-11-30)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/74483r-eng.php

rss-es

Health Canada: COVID-19 health product industry

Murilo Freitas - 12:15, 27 de noviembre de 20201,681

Health Canada and COVID-19 health product industry

COVID-19 health product industry – Canada.ca

rss-es

Brasil: Conheça as ações da Anvisa para enfrentamento da pandemia COVID-19

Murilo Freitas - 11:56, 27 de noviembre de 20201,490

Notícias

Vacina: nota de esclarecimento da Anvisa

26/11/2020 16h53

Vacina: Anvisa recebe documentos para submissão contínua

Empresa Pfizer protocolou documentos relativos às fases não-clínicas e clínicas I e II. A submissão contínua ainda não é o pedido de registro.

26/11/2020 13h50

Webinar da Anvisa: atuação da farmacovigilância na pandemia

Na terça-feira (1º/12), às 15h, a Agência irá realizar um seminário virtual sobre as ações de farmacovigilância no enfrentamento da Covid-19. Participe!

25/11/2020 09h48